The Globe and Mail reports in its Wednesday, Sept. 13, edition that Stifel analyst Ian Gillies remains "positive" on the organic revenue growth prospects for Canadian engineering and construction firms, believing the spending outlook for customers will bring "above-trend" gains through 2025. The Globe's David Leeder writes that accordingly, Mr. Gillies boosted his share target for Stantec by $7 to $105. Mr. Gillies continues to rate the shares "buy." Analysts on average target the shares at $97.55. Mr. Gillies says in a note: "High-quality earnings and top-tier management, while offering a 23-25E EPS CAGR of 14.4 per cent. M&A remains a key component of the growth story, with spare capacity of $1,685 mm. Valuation is expensive at 19.6 times 2025 P/ E, but this should compress as M&A is announced. An investor day in early December, 2023, could be a positive catalyst for the stock. Stantec remains on the Stifel Select List and should be a core holding." The Globe reported on June 6 that Mr. Gillies was holding on to his "buy" recommendation for Stantec. The shares could then be had for $81.78. The Globe reported on July 21 that CIBC rated Stantec "outperformer." It was then worth $88.75.